/

/

Inside the Billionaire Takeover of Lykos—and Rick Doblin’s Comeback

Fri, Mar 7

Perspectives

A billionaire takeover is set to reshape Lykos Therapeutics, and Rick Doblin is backing the deal in hopes of reclaiming influence. Will this move restore MDMA therapy’s original vision—or tighten corporate control? Our latest: https://t.co/FqwJ1pjpgo

0276

As MDMA therapy hangs in the balance, a high-stakes power shift is underway. But will it bring real change or just new faces at the top?

Discover